130 related articles for article (PubMed ID: 15854047)
1. Osteopontin expression correlates with melanoma invasion.
Zhou Y; Dai DL; Martinka M; Su M; Zhang Y; Campos EI; Dorocicz I; Tang L; Huntsman D; Nelson C; Ho V; Li G
J Invest Dermatol; 2005 May; 124(5):1044-52. PubMed ID: 15854047
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
[TBL] [Abstract][Full Text] [Related]
3. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
5. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin expression in plasma of melanoma patients and in melanocytic tumours.
Maier T; Laubender RP; Sturm RA; Klingenstein A; Korting HC; Ruzicka T; Berking C
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1084-91. PubMed ID: 21838826
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
[TBL] [Abstract][Full Text] [Related]
8. [Expression of osteopontin mRNA and its protein in colorectal cancer and liver metastatic tissues].
Ding L; Zheng S; Cao J
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):970-3. PubMed ID: 12181091
[TBL] [Abstract][Full Text] [Related]
9. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
[TBL] [Abstract][Full Text] [Related]
10. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.
Kääriäinen E; Nummela P; Soikkeli J; Yin M; Lukk M; Jahkola T; Virolainen S; Ora A; Ukkonen E; Saksela O; Hölttä E
J Pathol; 2006 Oct; 210(2):181-91. PubMed ID: 16924594
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.
Reed JA; McNutt NS; Prieto VG; Albino AP
Am J Pathol; 1994 Jul; 145(1):97-104. PubMed ID: 8030760
[TBL] [Abstract][Full Text] [Related]
12. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
13. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC
Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129
[TBL] [Abstract][Full Text] [Related]
14. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
16. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
[TBL] [Abstract][Full Text] [Related]
17. cDNA-array profiling of melanomas and paired melanocyte cultures.
Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin expression correlates with melanoma invasion.
Denhardt D
J Invest Dermatol; 2005 May; 124(5):xvi-xviii. PubMed ID: 15854023
[No Abstract] [Full Text] [Related]
19. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of osteopontin in colorectal cancer and liver metastatic tissues].
Ding L; Zheng S
Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):773-5. PubMed ID: 12487883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
